AHA Scientific Sessions 2021. Statin-associated muscle symptoms complicate treatment initiation and adherence; a new mHealth tool shows promise in reducing treatment cessation.

AHA Scientific Sessions 2021: Blood pressure reductions to clinical targets were achieved by patients with sustained hypertension through a remote health care delivery program during the COVID-19 pandemic.

In the first review of its kind, authors found encouraging evidence supporting the use of hypnosis for chronic neuropathic pain treatment. Find key results in our new slideshow.

A young medical student, native of Peru and now resident of Georgia in the US, relates her early education in health care disparities, first in Peru, then in her adopted home.

AHA Scientific Sessions 2021: New research found living in socially vulnerable neighborhoods increased the risk of myocardial infarction, stroke, or death among hospitalized COVID-19 patients.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

AHA 2021: E-cigarette users were found to have a 15% higher risk of a cerebrovascular accident at a younger age than those who smoked combustible tobacco cigarettes.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Finerenone was associated with a 20% lower risk of end-stage kidney disease among patients with T2D and CKD, according to authors of the FIDELITY analysis.

AHA Scientific Sessions 2021: National study of over 2.9 million young Black adults showed increased rates of CVD risk factors and worsened hospital outcomes between 2007 and 2017.

Efficacy of COVID-19 vaccines from Pfizer, Moderna, and J&J fell between 35% and 85% among nearly 800 000 US veterans, found a consortium of investigators.

The Pfizer study was stopped early for efficacy and the company plans to submit data to the US FDA for Emergency Use Authorization as soon as possible, according to a statement.

Semaglutide 2.4 mg led to clinically significant weight loss and improvements in cardiometabolic risk factors in adults with moderate or severe obesity, suggests new research from ObesityWeek 2021.

The evidence that obesity is pathophysiologic dysfunction in the human body places it squarely in the realm of chronic disease, according to obesity specialist Kaplan. Let’s treat it accordingly.

Primary care leadership is essential to the future of obesity medicine, says Kaplan, but treatment needs to be within the normal scope of primary care practice. Hear him explain.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Recognizing obesity as chronic pathophysiologic dysfunction and explaining that to a patient will make them remarkably more receptive to all other discussions about treatment, says obesity specialist Kaplan.

ObesityWeek 2021. Weight loss with semaglutide was more than 2 times greater than with liraglutide in the 68-week placebo-controlled trial of the 2 GLP-1 RAs.

CDC Director Rochelle Walensky officially endorsed Pfizer's COVID-19 vaccine in children aged 5 to 11 years, following recommendation from ACIP.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.